Asparaginase Activity Monitoring (AAM) in Adult Patients With Acute Lymphoblastic Leukemia (ALL)

NCT03668392 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped low enrollment rate

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: Asparaginase

Sponsor

Gruppo Italiano Malattie EMatologiche dell'Adulto